Different factors may influence the decision
After adjustment for age, sex, baseline BMI, baseline HbA1c, and hepatosteatosis grade, semaglutide remained independently associated with greater percentage weight loss at 6 months (adjusted = 6.16% points
However, for larger SNAC concentrations, deviations from a simple 1:1 binding model were observed, which is consistent with the formation of larger, dynamic SNAC aggregates that are also observed in DLS (Fig
6 Overall Survival (OS): Data from MD Anderson Cancer Center showed that patients on GLP-1 RAs had a significantly higher median OS compared with controls (median not reached with GLP-1 RAs vs 24.1 years for control
If ongoing trials confirm the early results, researchers think the drug could become one of the most powerful weight-loss medications ever developed
Thats when your body truly begins to unlock its full potential